SUPERNUS PHARMACEUTICALS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2020-06-30 was $981.00K, a 28.76% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2019-06-30 was $1.38M, a 16.30% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2018-06-30 was $1.18M.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2019 was $2.45M, a 10.82% increase from fiscal 2018.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2018 was $2.21M, a 17.00% increase from fiscal 2017.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2017 was $1.89M, a 26.37% increase from fiscal 2016.
- SUPERNUS PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2016 was $1.49M, a 60.65% increase from fiscal 2015.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2020-06-30 | $981.00K 10-Q · filed 2020-08-17 | |
| 2019-12-31 | $2.45M 10-K · filed 2020-02-28 | |
| 2019-06-30 | $1.38M 10-Q · filed 2020-08-17 | |
| 2018-12-31 | $2.21M 10-K · filed 2020-02-28 | |
| 2018-06-30 | $1.18M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $1.89M 10-K · filed 2020-02-28 | |
| 2016-12-31 | $1.49M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $930.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $516.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $444.00K 10-K/A · filed 2017-01-20 | |
| 2012-12-31 | $223.00K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |